Danaher Corporation vs JetBlue Airways Corporation — how do they compare? Danaher Corporation trades at $206.75 (market cap $145.83B), while JetBlue Airways Corporation trades at $5.88 (market cap $2.19B). The key difference: Danaher Corporation is far larger — about 66.6× JetBlue Airways Corporation's market cap, and Danaher Corporation pays a 0.77% dividend while JetBlue Airways Corporation pays none. Which is the better fit depends on your goals.
| DHR | JBLU | |
|---|---|---|
Market Cap | $145.83B | $2.19B |
Sector | Health | Industrials |
52-Week High | $242.05 | $6.46 |
52-Week Low | $161.91 | $4.03 |
Enterprise Value | $168.04B | $9.56B |
Dividend Yield | 0.77% | — |
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $209.26, up 2.2% today, with strong technical momentum as the price sits above key support levels. The company has consistently beaten earnings estimates in recent quarters, with Q3 2026 EPS expected at $1.92. Fundamentals show robust profitability with a 58.51% gross margin and 15.95% net income margin, though revenue growth has been modest. Analyst sentiment is overwhelmingly positive with 69% buy ratings and a $202.33 consensus price target. Recent news highlights the acquisition of Masimo and new product launches in its biotechnology segment.
The outlook for DHR remains favorable driven by earnings beats and strategic acquisitions, but investors face risks from elevated valuation multiples and potential macroeconomic headwinds. The stock's current technical overbought condition suggests near-term consolidation may occur, yet long-term growth prospects in life sciences support a bullish stance. Key watch points include Q3 2026 earnings results and integration progress of recent acquisitions.
JetBlue (JBLU) trades at $5.87, up 4.08% today, with a bullish technical signal from moving averages but mixed oscillators. The company reported a Q2 2026 earnings beat with a loss of $0.66 per share versus expectations of $0.69, though it has missed estimates in two of the last three quarters. Recent news includes Citigroup's downgrade to Sell on August 11, 2026, citing geopolitical risks, while the company introduced new fare structures and lounge accolades.
Outlook remains challenging with persistent net losses and negative margins, but cost management and strategic initiatives like the 2028 profit target offer potential upside. Key risks include high fuel costs, debt levels, and competitive pressure. Analyst consensus is cautious with a $5.18 price target and 62% Hold ratings, suggesting limited near-term growth amid operational headwinds.
Trailing returns across standard periods
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It carries over millions of customers with an average of more than 1,000 daily flights and served approximately 99 destinations in the United States, the Caribbean, and Latin America. The company currently operates Airbus A321, Airbus A320, and Embraer E190 aircraft types.
Read more on JBLU →